81 related articles for article (PubMed ID: 358092)
1. Chronic graft-versus-host disease (GVHD) [proceedings].
Kolb HJ; Wundisch GF; Bender C; Rodt H; Thiel E; Grosse-Wilde H; Thierfelder S
Pathol Biol (Paris); 1978 Jan; 26(1):52. PubMed ID: 358092
[No Abstract] [Full Text] [Related]
2. Treatment of aplastic anemia.
Gordon-Smith EC
Prog Clin Biol Res; 1984; 148():335-41. PubMed ID: 6379671
[No Abstract] [Full Text] [Related]
3. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP
Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661
[No Abstract] [Full Text] [Related]
4. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
Smith BR; Guinan EC; Parkman R; Ferrara J; Levey RH; Nathan DG; Rappeport JM
Transplantation; 1985 Jun; 39(6):671-3. PubMed ID: 3890295
[No Abstract] [Full Text] [Related]
6. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A;
Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791
[TBL] [Abstract][Full Text] [Related]
7. The immunogenetics of chronic graft versus host disease and its relevance for the graft versus leukemia effect.
van Rood JJ; Goulmy E; van Leeuwen A
Prog Clin Biol Res; 1987; 244():433-8. PubMed ID: 3310005
[No Abstract] [Full Text] [Related]
8. Graft versus host disease prophylaxis today.
Martelli MF; Aversa F
Bone Marrow Transplant; 1991; 7 Suppl 2():112-6. PubMed ID: 1908726
[No Abstract] [Full Text] [Related]
9. Treatment of GVH with ATG [proceedings].
Gluckman E; Devergie A; Marty M; Bussel A; Boiron M; Bernard J
Pathol Biol (Paris); 1978 Jan; 26(1):51. PubMed ID: 358091
[No Abstract] [Full Text] [Related]
10. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
Kinnamon KE; Blackwell LH; Ledney GD
Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088
[No Abstract] [Full Text] [Related]
11. Treatment of aplastic anemia.
Gale RP
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):117-26. PubMed ID: 3914736
[No Abstract] [Full Text] [Related]
12. [Decrease of chronic graft-versus-host disease by adding anti-human thymocyte globulin to the conditioning regimen].
Wu BY; Guo KY; Song CY; Zhang AL; Yan DA; Yang YL; Xiao LL
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):91-4. PubMed ID: 14990048
[TBL] [Abstract][Full Text] [Related]
13. [Aplastic anemia].
Dorantes S; de la Soledad Córdova M; Pizzuto J; Gónzalez Llaven J
Gac Med Mex; 1989; 125(11-12):341-60. PubMed ID: 2699298
[No Abstract] [Full Text] [Related]
14. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
[TBL] [Abstract][Full Text] [Related]
15. The combined use of Flu/ATG in nonmyeloablative SCT for severe aplastic anemia with multiple earlier transfusions.
Niparuck P; Ungkanont A; Ativitavas T; Jootar S
Bone Marrow Transplant; 2009 Jun; 43(11):887-9. PubMed ID: 19079311
[No Abstract] [Full Text] [Related]
16. Bone marrow transplantation.
van Bekkum DW
Transplant Proc; 1971 Mar; 3(1):53-7. PubMed ID: 4398503
[No Abstract] [Full Text] [Related]
17. Clinical uses of anti-thymocyte globulin (ATGAM), Part II.
Gilbert C
N C Med J; 1984 Dec; 45(12):773-5. PubMed ID: 6392895
[No Abstract] [Full Text] [Related]
18. GVHD suppression by incubation of bone marrow grafts with anti-T-cell globulin: effect in the canine model and application to clinical bone marrow transplantation.
Rodt H; Kolb HJ; Netzel B; Rieder I; Janka G; Belohradsky B; Haas RJ; Thierfelder S
Transplant Proc; 1979 Mar; 11(1):962-6. PubMed ID: 377731
[No Abstract] [Full Text] [Related]
19. Antithymocyte globulin therapy for steroid-resistant acute graft versus host disease.
Ballesteros M; Ferrá C; Serrano D; Batlle M; Ribera JM; Díez-Martín JL
Am J Hematol; 2008 Oct; 83(10):824-5. PubMed ID: 18683868
[No Abstract] [Full Text] [Related]
20. In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.
Kröger N; Zabelina T; Krüger W; Renges H; Stute N; Rischewski J; Sonnenberg S; Ayuk F; Tögel F; Schade U; Fiegel H; Erttmann R; Löliger C; Zander AR
Bone Marrow Transplant; 2002 Apr; 29(8):683-9. PubMed ID: 12180114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
